Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-38,968
Closed -$454K 889
2024
Q1
$454K Buy
38,968
+7,140
+22% +$79K ﹤0.01% 1707
2023
Q4
$356K Buy
31,828
+978
+3% +$8.99K ﹤0.01% 1852
2023
Q3
$476K Buy
30,850
+1,096
+4% +$18.4K ﹤0.01% 1638
2023
Q2
$564K Buy
+29,754
New +$522K ﹤0.01% 1572
2022
Q2
Sell
-4,899
Closed -$18K 3147
2022
Q1
$18K Sell
4,899
-346
-7% -$2.23K ﹤0.01% 3038
2021
Q4
$69K Sell
5,245
-90
-2% -$1.42K ﹤0.01% 2858
2021
Q3
$105K Sell
5,335
-127
-2% -$2.32K ﹤0.01% 2787
2021
Q2
$102 Buy
5,462
+610
+13% +$13.6K ﹤0.01% 2871
2021
Q1
$115 Buy
4,852
+13
+0.3% +$300 ﹤0.01% 2643
2020
Q4
$118 Buy
4,839
+945
+24% +$24.2K ﹤0.01% 2571
2020
Q3
$100K Buy
3,894
+2,095
+116% +$66.4K ﹤0.01% 2537
2020
Q2
$36K Buy
1,799
+60
+3% +$1.46K ﹤0.01% 2970
2020
Q1
$44K Sell
1,739
-100
-5% -$2.92K ﹤0.01% 2732
2019
Q4
$48K Buy
+1,839
New +$51.2K ﹤0.01% 2888

Other funds holding ETNB

American International Group's ETNB Position: Q2 2024 in Review

American International Group sold out of 89bio (ETNB) in Q2 2024, closing a stake of 38,968 shares — an estimated $454K sold.

American International Group first reported a position in ETNB in Q4 2019 and held it in 14 quarters. The position peaked at $564K in Q2 2023. 145 funds tracked by Wall St. Rank hold ETNB as of Q2 2024.

  • American International Group reported no remaining 89bio position as of Q2 2024 after selling out during the quarter.
  • American International Group sold 38,968 89bio shares in Q2 2024, an estimated $454K.
  • American International Group first reported a position in 89bio in Q4 2019 and held it in 14 quarters.
  • American International Group's 89bio position peaked at $564K in Q2 2023.
  • 145 funds tracked by Wall St. Rank held 89bio as of Q2 2024.

Based on American International Group's 13F filing for Q2 2024, filed 13 Aug 2024.